RE: LeoThread 2025-04-13 20:15
You are viewing a single comment's thread:
- Roflumilast is an adjunct therapy for patients with recurrent COPD exacerbations and/or bronchitis-like symptoms, to be used with pulmonary rehabilitation (COPD severity group E based on GOLD criteria),
0
0
0.000
when standard therapy with LABA (long-acting B agonist), LAMA (long acting muscarinic antagonist), and inhaled glucocorticoid are insufficient